{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:19:21Z","timestamp":1784193561129,"version":"3.55.0"},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,7,15]]},"DOI":"10.2169\/internalmedicine.4416-20","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T22:10:18Z","timestamp":1586988618000},"page":"1721-1726","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Characteristics of Epidemic Myalgia Associated with Human Parechovirus Type 3 during the Summer of 2019"],"prefix":"10.2169","volume":"59","author":[{"given":"Kenta","family":"Orimo","sequence":"first","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Okabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideji","family":"Hashida","sequence":"additional","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mizuta K, Kuroda M, Kurimura M, et al. Epidemic myalgia in adults associated with human parechovirus type 3 infection, Yamagata, Japan, 2008. Emerg Infect Dis  18: 1787-1793, 2012.","DOI":"10.3201\/eid1811.111570"},{"key":"2","unstructured":"2. Mizuta K, Yamakawa T, Nagasawa H, et al. Epidemic myalgia associated with human parechovirus type 3 infection among adults occurs during an outbreak among children: findings from Yamagata, Japan, in 2011. J Clin Virol 58: 188-193, 2013."},{"key":"3","unstructured":"3. Mizuta K, Yamakawa T, Kurokawa K, et al. Epidemic myalgia and myositis associated with human parechovirus type 3 infections occur not only in adults but also in children: findings in Yamagata, Japan, 2014. Epidemiol Infect 144: 1286-1290, 2016."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yamakawa T, Mizuta K, Kurokawa K, et al. Clinical characteristics of 17 adult patients with epidemic myalgia associated with human parechovirus type 3 infection. Rinsho Shinkeigaku (Clin Neurol) 57: 485-491, 2017 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.cn-001035"},{"key":"5","unstructured":"5. Williams WO. Bornholm disease survey 1956, 1957 and 1958. J Coll Gen Pract 4: 181-213, 1961."},{"key":"6","unstructured":"6. Kurimura M, Mizuta K, Yamakawa T, et al. Human parechovirus type 3 associated myalgia\/myositis: epidemic myalgia as an emerging infectious diseases. Neurol Med  86: 307-314, 2017 (in Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tanaka S, Aoki Y, Matoba Y, et al. Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014. Microbiol Immunol 60: 854-858, 2016.","DOI":"10.1111\/1348-0421.12456"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Karelehto E, Brouwer L, Benschop K, et al. Seroepidemiology of parechovirus A3 neutralizing antibodies, Australia, the Netherlands, and United States. Emerg Infect Dis 25: 148-152, 2019.","DOI":"10.3201\/eid2501.180352"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamamoto SP, Kaida A, Naito T, et al. Human parechovirus infections and child myositis cases associated with genotype 3 in Osaka City, Japan, 2014. J Med Microbiol 64: 1415-1424, 2015.","DOI":"10.1099\/jmm.0.000167"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Florence JM, Pandya S, King WM, et al. Intrarater reliability of manual muscle test (Medical Research Council Scale) grades in Duchenne's muscular dystrophy. Phys Ther 72: 115-122, discussion 122-126, 1992.","DOI":"10.1093\/ptj\/72.2.115"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Harvala H, Robertson I, McWilliam Leitch EC, et al. Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol 46: 3446-3453, 2008.","DOI":"10.1128\/JCM.01207-08"},{"key":"12","unstructured":"12. Racaniello VR. Picornaviridae: the viruses and their replication. In: Fields virology. 6th ed. vol. 1. Knipe DM, Howley PM, Eds. Lippincott Williams and Wilkins, Philadelphia, PA, 2013: 610-664."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ito M, Yamashita T, Tsuzuki H, Takeda N, Sakae K. Isolation and identification of a novel human parechovirus. J Gen Virol 85: 391-398, 2004.","DOI":"10.1099\/vir.0.19456-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Watanabe K, Oie M, Higuchi M, Nishikawa M, Fujii M. Isolation and characterization of novel human parechovirus from clinical samples. Emerg Infect Dis 13: 889-895, 2007.","DOI":"10.3201\/eid1306.060896"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ito M, Yamashita T, Tsuzuki H, et al. Detection of human parechoviruses from clinical stool samples in Aichi, Japan. J Clin Microbiol 48: 2683-2688, 2010.","DOI":"10.1128\/JCM.00086-10"},{"key":"16","unstructured":"16. Aizawa Y, Suzuki Y, Watanabe K, Oishi T, Saitoh A. Clinical utility of serum samples for human parechovirus type 3 infection in neonates and young infants: the 2014 epidemic in Japan. J Infect 72: 223-232, 2016."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kolehmainen P, Oikarinen S, Koskiniemi M, et al. Human parechoviruses are frequently detected in stool of healthy Finnish children. J Clin Virol 54: 156-161, 2012.","DOI":"10.1016\/j.jcv.2012.02.006"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Esposito S, Rahamat-Langendoen J, Ascolese B, Ascolese B, Senatore L, Castellazzi L, Niesters HG. Pediatric parechovirus infections. J Clin Virol 60: 84-89, 2014.","DOI":"10.1016\/j.jcv.2014.03.003"},{"key":"19","unstructured":"19. National Institute of Infectious Diseases. IASR Topics Graphs (Mumps virus\/Hepatitis A virus\/Enterovirus 68\/Parechovirus\/RSV). [Internet]. [cited 2016 Dec 8]. Available from: https:\/\/www.niid.go.jp\/niid\/en\/typhi-m\/iasr-reference\/510-graphs\/4565-iasrgtopicse.html"},{"key":"20","unstructured":"20. Hirayama K. [Tendon reflex]. In: [Neurological Semiology vol 2]. 2nd ed. Bunkodo, Tokyo, 2010: 471 (in Japanese)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Findlay AR, Goyal NA, Mozaffar T. An overview of polymyositis and dermatomyositis. Muscle Nerve 51: 638-656, 2015.","DOI":"10.1002\/mus.24566"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med 366: 2294-2304, 2012.","DOI":"10.1056\/NEJMra1114525"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Umapathi T, Li Z, Verma K, Yuki N. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barr\u00e9 syndrome. Clin Neurophysiol 126: 2376-2380, 2015.","DOI":"10.1016\/j.clinph.2015.01.016"},{"key":"24","unstructured":"24. Hu JJ, Kao CL, Lee PI, et al. Clinical features of influenza A and B in children and association with myositis. J Microbiol Immunol Infect 37: 95-98, 2004."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Agyeman P, Duppenthaler A, Heininger U, Aebi C. Influenza-associated myositis in children. Infection 32: 199-203, 2004.","DOI":"10.1007\/s15010-004-4003-2"},{"key":"26","unstructured":"26. Sham C, Tse K. Review of children diagnosed with acute myositis of calves admitted to a regional hospital in Hong Kong in the period 2003-2012. HK J Paediatr 20: 145-150, 2015."},{"key":"27","unstructured":"27. Paliwal VK, Garg RK, Juyal R, et al. Acute dengue virus myositis: a report of seven patients of varying clinical severity including two cases with severe fulminant myositis. J Neurol Sci 300: 14-18, 2011."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev 21: 473-494, 2008.","DOI":"10.1128\/CMR.00001-08"},{"key":"29","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.29.10.1323","volume":"29","author":"ET Gamboa","year":"1979","unstructured":"29. Gamboa ET, Eastwood AB, Hays AP, Maxwell J, Penn AS. Isolation of influenza virus from muscle in myoglobinuric polymyositis. Neurology 29: 1323-1335, 1979.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/14\/59_4416-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T03:32:12Z","timestamp":1595043132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/14\/59_4416-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":29,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4416-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]}}}